Published in Genetics and Environmental Business Week, February 22nd, 2007
The Roskamp Institute, which is devoted to finding treatments for Alzheimer disease, has been researching drugs that have the potential to stop the production of B-amyloid.
"When B-amyloid builds up in humans, patients develop Alzheimer's disease," said Mullan, director of the Roskamp Institute. "By stopping its production we can potentially stop...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.